Vol 2 Chapter 585: Kuafu’s $30 billion annual investment plan

"Yes, boss, and I have a new idea. Boss, you can ask Bizet Group to increase the proportion of research investment in biopharmaceuticals, so that they can invest more angel investment funds to invest in those who have ideas but do not The biological R&D teams and individuals who fund specific experiments in the laboratory, let them do their own research!
Regardless of whether they can find any results, we are happier when there are results and can continue to increase investment. There is no specific result and there is no need to be disappointed.
Because even if their research is wrong, or if there are results, there is not much benefit. Their research data and R&D process are also a lot of gains. At least it can save a lot of our company headquarters. Detours, save more development time!
I think that with the current development speed of the BizArt Group and the behind-the-scenes support of your boss, it is very easy for them to invest 5 billion US dollars in the biopharmaceutical field every year.
And our company here can also allow our angel investment department to make angel investments in the biopharmaceutical field. The funds here are more sufficient, and there is no problem with investing 10 billion US dollars every year!
With the investment of more than 15 billion U.S. dollars per year on these obvious investments, it is basically possible to make global investments in multiple biopharmaceutical fields!
These investments can bring huge R&D data to the company, and these data, after the company’s integration, can make the company’s R&D database very substantial, allowing the company to have more data when conducting related R&D. support!
We can also use our own private funds to invest in related fields. The Daily Investment Management Company under my charge can be responsible for this investment. With our current capital scale, another US$15 billion investment is also a sprinkling of water!
This money can be invested in companies and countries that are hostile to us, and with a little money, they can help us in various aspects of biopharmaceutical research and development. I am happy to think about it!
Such over-the-top investments and under-the-cover investments, together, we will invest more than 30 billion U.S. dollars in angel investment funds in one year, and we believe it can greatly advance the research and development process in the biopharmaceutical field!
After all, the amount of our investment is already more than the total global investment in the biopharmaceutical field every year. It would be a strange thing if such a large amount of capital cannot advance the research and development process in related fields!
After all, our investment is not purely profit-seeking. For some biological research and development work that has no profit, there is almost no way to obtain angel investment, but these researches abandoned by capital are also very valuable to us!
For example, boss, you also know that the current investment hotspots in the field of biopharmaceuticals are in the research of anti-cancer drugs and other related new drugs. Few pharmaceutical companies conduct research on the research and development of some niche diseases, even if they do, then Large companies will do it only after receiving state subsidies, and the drugs developed are all sky-high prices!
However, there are more niche diseases that no one wants to study at all, just because such research does not have much benefit even if it is studied. Capital is profitable, and few people are willing to buy and sell money!
However, our company can invest in these niche diseases in external angel investment. On the one hand, this can increase the social impact of our company. On the other hand, I think the research on these niche diseases is also very good. importance!
These unknown diseases caused by genetic lesions that are still very new to the biopharmaceutical field, or known diseases with only tens of thousands of affected people, I think if we can conduct more research on their genetic lesions, we will It will enable us to more accurately grasp our own human genes.
Moreover, we can conduct more in-depth research on how to solve real genetic diseases, which will bring more data and R&D experience to our company's future research work on more complex space genetic diseases.
This is very important for the company's future. After all, in the space environment, what kind of mutations our human genes will have is possible. If we don't have research preparations in this area, we will suffer in the future!
This is my idea. I hope you, boss, can let the research of our company's biopharmaceutical field involve experts from all over the world, and the research of these people will also allow the biopharmaceutical companies in our company's headquarters to get very huge data. , It also allows them to maintain the greatest work enthusiasm. After all, so many competitors outside are also conducting related research, if they don’t work hard, they will be eliminated! "
Kuafu introduced his thoughts in detail, and his thoughts also proved that his current wisdom has been able to think independently, which is an incredible thing for artificial intelligence~EbookFREE.me~but It is a very normal thing for intelligent life, which proves once again that Kuafu can now be counted as a primary intelligent life!
"Okay! Kuafu, your idea is very good! Although 30 billion US dollars a year is not a small number, we still give it up, and it's not that these investments will be lost, and there will always be benefits in the future. Maybe a certain investment will bring us surprises!
Anyway, angel investment is the same thing. Investing in one hundred projects, as long as one can succeed, it can make up for the loss. If several more projects are successful, then you can make money. We may make the most investment every year. It only needs to invest 10 billion US dollars!
I think we lose 10 billion U.S. dollars each year at most. We still lose this money, and the R&D data in these investments is our biggest gain. We can buy these R&D with a loss of 10 billion U.S. dollars each year. I think the data is very worthwhile!
Then our own investment will be handed over to your Daily Investment Management Company. I will explain it to BizArt Group. As for the company, I will explain Jiang Yuting! "Lei Tiantang said happily.
Biological drugs refer to the use of research results in microbiology, biology, medicine, biochemistry, etc., from organisms, biological tissues, cells, organs, body fluids, etc. A class of products for prevention, treatment, and diagnosis that are manufactured by comprehensively utilizing the scientific principles and methods of microbiology, chemistry, biochemistry, biotechnology, pharmacy, etc.
There are too many research categories involved in this field. Just relying on the research of a biopharmaceutical company established in the Lei Tian Tang Project, only God knows when there will be results.
(https://)
Please remember the domain name of this book's first publication:. Mobile version reading URL: